Neurology® Podcast
American Academy of Neurology
The Neurology Podcast provides practical information for neurologists and clinicians to practice the best possible medicine for patients. Examining methods and findings in peer-reviewed journals, the show provides insights that impact clinical practice and patient care. From the journal Neurology and the American Academy of Neurology, providing education and expert analysis since 2007.
Episodes
Mentioned books
Aug 1, 2021 • 1h 29min
Perspectives on Aducanumab Approval (Neurology Recall August 2021)
This month’s replay of past episodes showcases a selection of interviews concerning the FDA approval of aducanumab for the treatment of Alzheimer disease from clinical, political, and economic perspectives. The selected interviews feature conversations between Dr. Gregg Day and Pam Belluck, Dr. Jeff Burns and Dr. Ron Peterson, Dr. Jason Crowell and Dr. Steve Pearson, and Dr. Jeff Burns and Dr. Daniel Gibbs.
Jul 26, 2021 • 17min
Impact of Thymectomy on Myasthenia Gravis Remission
Dr. Stacey Clardy discusses the impact of surgical approaches to thymectomy upon remission rates in myasthenia gravis with Dr. Joseph Shrager.
Jul 19, 2021 • 26min
Symptoms and Incidence of RCVS; Optimizing Stroke Prevention in Atrial Fibrillation
In the first segment, Will Rondeau discusses the symptoms, incidence, and resource utilization of reversible cerebrovascular vasoconstriction syndrome with Dr. Jessica Magid-Bernstein. In the second part of the podcast, Dr. Andy Southerland discusses the optimization of atrial fibrillation treatment and stroke prevention with Dr. Seemant Chaturvedi.
Jul 12, 2021 • 30min
Illness in Overseas U.S. Embassies Employees; Afferent Baroreflex Failure
In the first segment, Dr. Alex Menze talks with Dr. Clifford Saper about Havana Syndrome and recent attacks on American diplomats. In the second part of the podcast, Dr. Jeff Ratliff discusses the natural history of afferent baroreflex failure with Dr. Guillaume Lamotte.
Jul 5, 2021 • 31min
Evaluations in First Episode Psychosis; Dr. Daniel Gibbs on his Battle with Alzheimer's
In the first segment, Dr. Gregg Day speaks with Dr. Josep Dalmau about NMDAR antibodies in patients with first episode psychosis and the utility of criteria for autoimmune psychosis. In the second part of the podcast, Dr. Jeff Burns talks to neurologist Dr. Daniel Gibbs about his Alzheimer’s disease diagnosis and experience participating in a clinical trial for aducanumab.
Jul 1, 2021 • 1h 19min
Management of Neurologic Conditions in Pregnancy (Neurology Recall July 2021)
This month's replay of past episodes showcases a selection of interviews on the impact of pregnancy on various neurologic disorders, featuring Drs. Page Pennell, Paula Emanuela Voinescu, Mary Angela O'Neal, Emma Ciafaloni, Raed Alroughani, Rae Bacharach, Annette Langer-Gould, Nicolas Collongues, and Petra Ijäs.
Jun 28, 2021 • 12min
SPECIAL REPORT: A Discussion with Mary Post (Part 2)
This second installment in our two-part series features Dr. Stacey Clardy in conversation with Mary Post, CEO of the American Academy of Neurology.
Jun 24, 2021 • 31min
SPECIAL REPORT on Aducanumab Approval: A Pulitzer Prize-winning Journalist's Perspective
Dr. Gregg Day speaks with Pam Belluck, an award-winning journalist at the New York Times, about her coverage of the recent FDA approval of aducanumab for Alzheimer disease treatment.
Jun 21, 2021 • 11min
SPECIAL REPORT: A Discussion With Mary Post (Part 1)
This first installment of a 2-part series features Dr. Stacey Clardy in conversation with Mary Post, CEO of the American Academy of Neurology.
Jun 19, 2021 • 12min
SPECIAL REPORT on Aducanumab Approval: Discussion with Cognitive Behavioral Neurologists
Dr. Jeff Burns, Director of the University of Kansas Alzheimer’s Disease Center, speaks with Dr. Ron Petersen, Director of the Mayo Clinic Alzheimer's Disease Center, about the recent FDA approval of aducanumab for the treatment of Alzheimer disease.
